🇺🇸 FDA
Patent

US 12365722

Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope

granted A61KA61K2039/505A61K39/42

Quick answer

US patent 12365722 (Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/505, A61K39/42, A61K45/06, A61P